Provexis Share Discussion Threads

[twodegrees] 11/5/2017 14:44

Thanks Bareknee,I somehow missed that due to seeing the rise in sales and the revenue that it would be generating.

[lafin] 11/5/2017 09:45

Oh no -Possible UK stroke epidemic coming soon
according to Telegraph.

[bareknee] 10/5/2017 20:48

TWODEGREES

I DON'T KNOW WHAT YOU MEAN ?
BOTH PLACINGS ARE SET AT 0.5P

bb

[twodegrees] 10/5/2017 18:41

ARE THE REVENUE JUMPS SUFFICIENT TO ENCOURAGE THE PLACING TO BE AT A REASONABLE PRICE OR ARE WE LOOKING AT SUB 0.50 AGAIN.

[librag] 03/5/2017 11:06

Hi SS, yes. I think this and other recent fundraising shows better regard for normal (is there such a thing on the boards?) shareholders. I'll be watching PrimaryBid with interest.

Bernie, he seems much better behaved these days. Saw my name on the blue channel and it brought back so many memories and a warm furry feeling.

edit: furry or fuzzy?

[senor_sensible] 03/5/2017 07:37

Libra, Nice RNS elsewhere today :-)

As expected here, raising funds from placement to insiders, also allowing pixies a chance to buy in too at same price. Chinese market is the key here...........

[bareknee] 02/5/2017 18:14

Crunchy Nut would have been a good username for Asshur's latest incarnation !

[librag] 02/5/2017 16:54

Try crunchy nut. Lovely.

[bareknee] 02/5/2017 13:49

Graham - fair point

It was early and I was only half way through my porridge !
Round about 30 to 35k for the half year then ?

[librag] 02/5/2017 11:50

Bernie:
From the RNS " ... launched at the end of June 2016 and it achieved sales of £7k in the three month period to 30 September 2016. In recent months, following some limited digital and other marketing investment, the rate of sales for the product has more than doubled relative to the initial launch period, ... "

Your "FF+ sales have more than doubled from a very low base though. We're presumably taliking about something less than 20k for the half year." is somewhat pessimistic. It's £21K at least for the current half year.

Splitting hairs? Moi? :)

[lafin] 24/4/2017 17:37

nothing to see here deleted.

[lafin] 24/4/2017 17:32

Libra Grump,
I asked you at the time,I think,which you thought would be better and I said " You're going to answer both" but I can't remember what you answered.

[oldham45] 24/4/2017 15:25

Absolutely

[oldham45] 24/4/2017 15:20

Fried mars bar (in oil), is weird but, but consumed.

[oldham45] 24/4/2017 15:19

Why not, you can get salted caramel?

[librag] 24/4/2017 15:09

lolcretin;
" ... which contributes to normal blood flow"

Far be it from me to interrupt your playground nonsense on the blue channel, but even you might see that if flavanols do the above, then to the average consumer, they're in the same market.

Peppa, you're wrong IMO. I guess it will be FAR easier to get people to take a pill from chocolate than one from tomatoes. I know which I'd prefer.

Reality check: the combination of reduced platelet activation plus increased vessel elasticity, might be synergistic.

Mars bar with a dash of tomato sauce anyone? Bernie?

[winner31] 23/4/2017 12:43

Hopefully get the funding news out of the way this week ,then we can move forward after a trading update next month

[lafin] 08/4/2017 19:03

I looked it up and found that it was already covered-had forgotten

[senor_sensible] 07/4/2017 11:56

I would not worry about that, I am co-designer on several patents and received a one off invention fee and no ongoing royalties, depends if work is paid for by PXS in which case they own the rights to the fruit of this work.

[lafin] 07/4/2017 09:01

So presumably they will get some kind of payment from PXS?

Sorry to complicate things-maybe doesn't really matter

[lafin] 07/4/2017 08:53

Patent for blood pressure bit is part owned by oslo university is it not?

[lafin] 07/4/2017 08:38

READ THIS CAREFULLY.
Provexis Signs Memorandum Of Understanding For China Product Research
[ 06 Apr 2017 10:43 ]

LONDON (Alliance News) - UK ingredients company Provexis PLC said on Thursday it has signed a Memorandum Of Understanding with Chinese dietary supplement business By Health Company Ltd, intended to result in a research and collaboration agreement for Provexis' tomato-extract product, Fruitflow.

Provexis and its Alliance partner, DSM Nutritional Products will also be working with By-Health to launch Fruitflow-based products into the Chinese market, starting in the second half of 2017.

The proposed research and collaboration agreement is to be signed later this year, and the resulting research programme is scheduled for completion in 2018.

Under the MoU, Provexis and By Health will provide primary funding for By-Health's research programme, focusing on the development of new products that contribute towards cardiovascular health, particularly blood pressure regulation.

Any products covered under Provexis' existing patents will be wholly owned by them, and Provexis will hold joint ownership over any new products developed as part of the programme.

"The company's Fruitflow technology is well placed to address the large and growing issue of cardiovascular health in China, and the MOU announced today and planned launch by By-Health of some Fruitflow based products in China are strongly Positive developments for Fruitflow and the Provexis business," Chairman of Provexis Dawson Buck said.

Shares in Provexis were up by 16% at 0.625 pence on Thursday morning.

By Dayo Laniyan; [e-mail]

[bareknee] 06/4/2017 13:47

Graham

I feel suitably chastised !

[underhill2] 06/4/2017 12:40

This is a very long term investment and hold. It could be at least 5 years before we see any real progress here in the share price. Profits need to be made !. Whilst this is very speculative and risky should this take off one day the rewards will follow. I have a modest holding here 1m shares . Only time will tell